Pharmacokinetic–pharmacodynamic modelling of QT interval prolongation following citalopram overdoses
- 1 December 2005
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 61 (2), 177-190
- https://doi.org/10.1111/j.1365-2125.2005.02546.x
Abstract
To develop a pharmacokinetic-pharmacodynamic model describing the time-course of QT interval prolongation after citalopram overdose and to evaluate the effect of charcoal on the relative risk of developing abnormal QT and heart-rate combinations. Plasma concentrations and electrocardiograph (ECG) data from 52 patients after 62 citalopram overdose events were analysed in WinBUGS using a Bayesian approach. The reported doses ranged from 20 to 1700 mg and on 17 of the events a single dose of activated charcoal was administered. The developed pharmacokinetic-pharmacodynamic model was used for predicting the probability of having abnormal combinations of QT-RR, which was assumed to be related to an increased risk for torsade de pointes (TdP). The absolute QT interval was related to the observed heart rate with an estimated individual heart-rate correction factor [alpha = 0.36, between-subject coefficient of variation (CV) = 29%]. The heart-rate corrected QT interval was linearly dependent on the predicted citalopram concentration (slope = 40 ms l mg(-1), between-subject CV = 70%) in a hypothetical effect-compartment (half-life of effect-delay = 1.4 h). The heart-rate corrected QT was predicted to be higher in women than in men and to increase with age. Administration of activated charcoal resulted in a pronounced reduction of the QT prolongation and was shown to reduce the risk of having abnormal combinations of QT-RR by approximately 60% for citalopram doses above 600 mg. Citalopram caused a delayed lengthening of the QT interval. Administration of activated charcoal was shown to reduce the risk that the QT interval exceeds a previously defined threshold and therefore is expected to reduce the risk of TdP.Keywords
This publication has 38 references indexed in Scilit:
- Sample Size, Power Calculations, and Their Implications for the Cost of Thorough Studies of Drug Induced QT Interval ProlongationPacing and Clinical Electrophysiology, 2004
- Differences Between Study-Specific and Subject-Specific Heart Rate Corrections of the QT Interval in Investigations of Drug Induced QTc ProlongationPacing and Clinical Electrophysiology, 2004
- Bayesian Measures of Model Complexity and FitJournal of the Royal Statistical Society Series B: Statistical Methodology, 2002
- Long QT syndromes and torsade de pointesThe Lancet, 1999
- Activated Charcoal Reduces the Need forN-Acetylcysteine Treatment After Acetaminophen (Paracetamol) OverdoseJournal of Toxicology: Clinical Toxicology, 1999
- QT interval change with age in an overtly healthy older populationClinical Cardiology, 1996
- Measurement of the QT interval and the risk associated with QTc interval prolongation: A reviewThe American Journal of Cardiology, 1993
- Inference from Iterative Simulation Using Multiple SequencesStatistical Science, 1992
- Gastrointestinal Clearance of Drugs with Activated CharcoalNew England Journal of Medicine, 1982